Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruxolitinib for Severe COVID-19 Respiratory Syndrome
NCT04414098Phase 2Unknown
- Start
- Jun 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ruxolitinib in coronavirus disease 2019 (COVID-19). Status: unknown.
02
Drugs
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04414098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04414098.